Silver Book Fact

Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.

Goldman, Dana P., Baoping Shang, Jayanta Bhattacharya, Alan M. Garber, Michael Hurd, Geoffrey F. Joyce, Darius N. Lakdawalla, Constantijn Panis, and Paul G. Shekelle. Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly. Health Affairs Web Exclusive Collection. 2005; 24(2). http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w5.r5v1

Reference

Title
Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly
Publication
Health Affairs Web Exclusive Collection
Publication Date
2005
Authors
Goldman, Dana P., Baoping Shang, Jayanta Bhattacharya, Alan M. Garber, Michael Hurd, Geoffrey F. Joyce, Darius N. Lakdawalla, Constantijn Panis, and Paul G. Shekelle
Volume & Issue
Volume 24, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • Since 1970, reduced mortality from heart disease has increased the value of life by about $1.5 trillion per year. The value of improvements in health care over the 20th century…  
  • Over the past 15 years, three classes of drugs have reduced mortality and improved symptoms of heart failure in patients who have decreased heart muscle function. These classes of drugs…  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.